9D5Z | pdb_00009d5z

Crystal structure of the human WDR5 in complex with LH168 compound


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.70 Å
  • R-Value Free: 
    0.189 (Depositor), 0.190 (DCC) 
  • R-Value Work: 
    0.139 (Depositor), 0.151 (DCC) 
  • R-Value Observed: 
    0.140 (Depositor) 

Starting Model: experimental
View more details

wwPDB Validation 3D Report Full Report

Validation slider image for 9D5Z

Ligand Structure Quality Assessment 


This is version 1.1 of the entry. See complete history

Literature

Discovery of an exquisitely selective WDR5 chemical probe accelerated by a high-quality DEL-ML Hit.

Hoffmann, L.Lenz, C.Farges, F.Kimani, S.W.Dopfer, J.Keller, S.Schwalm, M.P.Holzmann, H.Kraemer, A.Dong, A.Li, F.Chau, I.Halabelian, L.Gstaiger, M.Muller, S.Knapp, S.Nemec, V.

(2025) RSC Chem Biol 6: 1585-1594

  • DOI: https://doi.org/10.1039/d5cb00109a
  • Primary Citation Related Structures: 
    9D5Z

  • PubMed Abstract: 

    Herein we present the rapid development of LH168, a potent and highly selective chemical probe for WDR5, streamlined by utilizing a DEL-ML (DNA encoded library-machine learning) hit as the chemical starting point. LH168 was comprehensively characterized in bioassays and demonstrated potent in cellulo target engagement at the WIN-site pocket of WDR5, with an EC 50 of approximately 10 nM, a long residence time, and exceptional proteome-wide selectivity for WDR5. In addition, we present the X-ray co-crystal structure and provide insights into the structure-activity relationships (SAR). In parallel, we developed a matched negative control compound as well as an alkyne analog (compound 16) to facilitate the development of bifunctional molecules. Taken together, we provide the scientific community with a well-characterized chemical probe to enable studies and functional manipulation of WDR5 in a cellular context, as this protein represents a therapeutically relevant target with scaffolding functions that influence multiple cellular processes.


  • Organizational Affiliation
    • Institute for Pharmaceutical Chemistry, Johann Wolfgang Goethe-University Max-von-Laue-Str. 9 D-60438 Frankfurt am Main Germany nemec@pharmchem.uni-frankfurt.de knapp@pharmchem.uni-franfurt.de.

Macromolecule Content 

  • Total Structure Weight: 70.06 kDa 
  • Atom Count: 5,271 
  • Modeled Residue Count: 604 
  • Deposited Residue Count: 624 
  • Unique protein chains: 1

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
WD repeat-containing protein 5
A, B
312Homo sapiensMutation(s): 0 
Gene Names: WDR5BIG3
UniProt & NIH Common Fund Data Resources
Find proteins for P61964 (Homo sapiens)
Explore P61964 
Go to UniProtKB:  P61964
PHAROS:  P61964
GTEx:  ENSG00000196363 
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupP61964
Sequence Annotations
Expand
Reference Sequence

Small Molecules

Ligands 2 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
A1A16
(Subject of Investigation/LOI)

Query on A1A16



Download:Ideal Coordinates CCD File
C [auth A],
F [auth B]
(3P)-N-[(2S)-1-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)-1-oxopentan-2-yl]-3-[1-ethyl-3-(trifluoromethyl)-1H-pyrazol-4-yl]-5-[(1H-imidazol-1-yl)methyl]benzamide
C29 H31 F3 N6 O2 S
UFKFTBGGMLIIME-DEOSSOPVSA-N
EDO

Query on EDO



Download:Ideal Coordinates CCD File
D [auth A],
E [auth A],
G [auth B],
H [auth B],
I [auth B]
1,2-ETHANEDIOL
C2 H6 O2
LYCAIKOWRPUZTN-UHFFFAOYSA-N

Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.70 Å
  • R-Value Free:  0.189 (Depositor), 0.190 (DCC) 
  • R-Value Work:  0.139 (Depositor), 0.151 (DCC) 
  • R-Value Observed: 0.140 (Depositor) 
Space Group: P 1
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 46.951α = 110.41
b = 61.185β = 91.22
c = 64.605γ = 112.2
Software Package:
Software NamePurpose
REFMACrefinement
HKL-3000data scaling
PHASERphasing

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 


Entry History 

& Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
Other private--

Revision History  (Full details and data files)

  • Version 1.0: 2025-02-19
    Type: Initial release
  • Version 1.1: 2026-09-02
    Changes: Database references